{"id":369249,"date":"2025-12-09T11:30:18","date_gmt":"2025-12-09T06:00:18","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=369249"},"modified":"2025-12-09T11:35:58","modified_gmt":"2025-12-09T06:05:58","slug":"cam-serum-institute-biocon-biologics-share-swap-deal-2025","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","title":{"rendered":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap"},"content":{"rendered":"
\n

Cyril Amarchand Mangaldas (“CAM<\/span>“) advised Serum Institute on the proposed sale of stake in Biocon Biologics to Biocon and subscription of shares in Biocon through a share swap, valued at INR 2250 Crore.<\/p>\n

The transaction team advising Serum was led by Anchal Dhir<\/span>, Partner, with assistance from Varun Kannan<\/span>, Senior Associate, Mahin Rai<\/span>, Senior Associate and Animesh Pandey<\/span>, Associate.<\/p>\n

Avaantika Kakkar<\/span>, Partner (Head – Competition) advised on competition law aspects of the transaction.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at ₹2,250 crore. The deal marks a significant restructuring in India’s biopharmaceutical sector.<\/p>\n","protected":false},"author":67011,"featured_media":369270,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[94474,94475,94476,94479,68835,94477,30960,94481,94478,94480,45759,94473],"class_list":["post-369249","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-biocon-biologics-transaction","tag-biocon-share-swap-deal","tag-biopharmaceutical-investment","tag-biotech-deal","tag-cam","tag-competition-law-advisory-pharma","tag-cyril-amarchand-mangaldas","tag-pharma-equity-transaction","tag-pharma-restructuring","tag-serum-biocon-deal-2025","tag-serum-institute","tag-serum-institute-stake-sale"],"yoast_head":"\nCyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-09T06:00:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T06:05:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/\",\"name\":\"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp\",\"datePublished\":\"2025-12-09T06:00:18+00:00\",\"dateModified\":\"2025-12-09T06:05:58+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp\",\"width\":886,\"height\":590,\"caption\":\"CAM Serum-Biocon Transaction\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap | SCC Times","description":"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap","og_description":"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-09T06:00:18+00:00","article_modified_time":"2025-12-09T06:05:58+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/","name":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp","datePublished":"2025-12-09T06:00:18+00:00","dateModified":"2025-12-09T06:05:58+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advised Serum Institute on the \u20b92,250 crore sale of its stake in Biocon Biologics and subscription of Biocon shares through a strategic share swap.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp","width":886,"height":590,"caption":"CAM Serum-Biocon Transaction"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/cam-serum-institute-biocon-biologics-share-swap-deal-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Serum-Biocon-Transaction.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":369560,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","url_meta":{"origin":369249,"position":0},"title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","author":"Editor","date":"December 11, 2025","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Biocon Biologics integration","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":369190,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/09\/khaitan-viatris-biocon-biologics-stake-sale-815-million\/","url_meta":{"origin":369249,"position":1},"title":"Khaitan & Co advised Viatris on its proposed sale of stake in Biocon Biologics to Biocon for USD 815 million","author":"Editor","date":"December 9, 2025","format":false,"excerpt":"Khaitan & Co advised Viatris on the USD 815 million sale of its stake in Biocon Biologics to Biocon via cash payment and preferential share allotment.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Viatris Biocon Biologics stake sale","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Viatris-Biocon-Biologics-stake-sale.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":372923,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/01\/16\/shardul-amarchand-mangaldas-advises-biocon-qip-4150-crore\/","url_meta":{"origin":369249,"position":2},"title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its \u20b94,150 crore Qualified Institutions Placement","author":"Editor","date":"January 16, 2026","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Biocon Limited on its \u20b94,150 crore Qualified Institutions Placement to fund the integration of Biocon Biologics and related debt repayment.","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Biocon Qualified Institutions Placement","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/01\/Biocon-Qualified-Institutions-Placement.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":308625,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/12\/07\/sam-advises-eris-lifesciences-limited-acquisition-of-dermatology-and-nephrology-branded-formulations-business-units\/","url_meta":{"origin":369249,"position":3},"title":"SAM advises Eris Lifesciences Limited on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"December 7, 2023","format":false,"excerpt":"Shardul Amarchand Mangaldas advised Eris Lifesciences Limited (\u201cEris\u201d) on its acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics Limited (\u201cBiocon\u201d) in India. The deal is valued at approximately INR 366 crores and the date of closing the deal was 10 November 2023. This acquisition marks the\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/12\/Texmaco-Rail-Engineering-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":317745,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/03\/19\/khaitan-co-advises-eris-lifesciences-limited-on-its-acquisition-of-the-branded-formulations-business-of-biocon-biologics-limited-in-india\/","url_meta":{"origin":369249,"position":4},"title":"Khaitan & Co advises Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India","author":"Bhumika Indulia","date":"March 19, 2024","format":false,"excerpt":"DEAL DETAILS Eris Lifesciences Limited | Acquisition of the Indian branded formulations business of Biocon Biologics Limited Khaitan & Co advised Eris Lifesciences Limited on its acquisition of the branded formulations business of Biocon Biologics Limited in India for a total consideration of INR 1,242 Crores. The acquisition helps augment\u2026","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Eris Lifesciences Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/03\/biocon.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":329063,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/08\/21\/cyril-amarchand-mangaldas-advises-kedaara-capital-and-partners-group-on-sale-of-controlling-stake-in-aavas-financiers-limited-to-cvc\/","url_meta":{"origin":369249,"position":5},"title":"Cyril Amarchand Mangaldas advises Kedaara Capital and Partners Group on Sale of Controlling Stake in Aavas Financiers Limited to CVC","author":"Bhumika Indulia","date":"August 21, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) is advising Kedaara Capital and Partners Group in relation to their sale of controlling stake","rel":"","context":"In "Law Firms News"","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Kedaara Capital and Partners Group","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/Kedaara-Capital-and-Partners-Group.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=369249"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369249\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/369270"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=369249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=369249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=369249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}